Trial Details

COMPLETED
Basic Information
Clinical ID c1046
Identifier NCT00207688
Trial Title A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: Infliximab 5 mg/kg|DRUG: Infliximab 10 mg/kg|DRUG: Placebo
Participant Information
Sponsor Janssen Research & Development, LLC
City Scottsdale
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2004-08-31
Primary Completion Date 2015-09-09
Completion Date 2015-09-09